Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 444

Document Document Title
WO/1994/008977A1
This invention relates to novel substituted caprolactams of formula (I), including 4-azacaprolactams, and derivatives thereof which inhibit HIV protease and are useful for treatment of HIV disease. Also included in this invention are pha...  
WO/1994/005671A1
The invention concerns an addition compound obtained by reacting C60 or C70 fullerenes with a diamine of formula (I) in which R1 is C2 to C4 alkylene or 1,2- or 1,3-cyclo-(C3 to C7)-alkylene and R2 and R3, which may be the same or differ...  
WO/1993/009133A1
This invention relates to a method of inhibiting platelet aggregation, and 1,4-diazocine compounds which are mimics of the peptide sequence Arg-Gly-Asp.  
WO/1993/007128A1
This invention relates to substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors, to pharmaceutical compositions comprising such compounds, and to methods of using these compounds for treating viral...  
WO/1993/007429A1
An air treatment plant, e.g. a freezing plant, for foodstuffs, comprises a housing (1), an elongate trough (11) provided therein for receiving the foodstuff to be treated, a heat exchanger (12) and a fan assembly (13) for producing an ai...  
WO/1992/019665A1
This invention concerns cyclic aromatic amide oligomer compositions and a process for preparing such cyclic oligomers.  
WO/1992/017460A1
Hydroxamic acid derivatives for use as medicaments, of formula (1), or a salt, solvate or hydrate thereof, in which R1 is hydrogen, C1-6alkyl, or -(CH2)n-A-R4 where n is from 0 to 6, A is a bond or an oxygen or sulphur heteroatom and R4 ...  
WO1992012133A3  
WO/1992/012133A2
Compounds of formula (I), wherein Q, X, R?1�, R?2�, R?9� and Z are as defined in the text, including compositions containing said compounds and a method for using them to control arthropods.  
WO/1992/006966A1
Thiol carboxylic acid derivatives, processes for their preparation and their use as collagenase inhibitors are described.  
WO/1991/005549A1
Novel benzoheterocyclic compounds of formula (I), wherein R?1¿ is H, halogen, alkyl, optionally substituted amino, alkoxy; R?2¿ is H, halogen, alkoxy, phenylalkoxy, OH, alkyl, optionally substituted amino, carbamoyl-alkoxy, optionally ...  
WO/1982/002199A1
New dibenzoxazonine, dibenz-oxazecine or dibenzo-oxaazacycloundecane derivatives and corresponding thia- and aza derivatives thereof, of the general formula I: (FORMULA) or a pharmaceutically acceptable acid addition salt or nitrogen oxi...  
WO/1980/002155A1
An antibacterial surfactant containing in an effective amount at least one of cyclic amides represented by the following general formula; (FORMULA) (wherein R represents an alkyl group, alkenyl group, alkylaryl group, alkylarylalkyl grou...  
JP6386026B2  
JP2018517753A
The present invention is formula (I) :The compound shown by [the inside of a formula and all the variable machines are as defining in a specification] or its stereoisomeric form, a tautomerism object, or the salt permitted in medicine is...  
JP2018039773A
To provide a nitrogen-containing nine-membered cycloalkyne to which various functional parts can easily be introduced.Introduction of functional part(s) is made easy by making nitrogen(s) constituting a ring of a nitrogen-containing nine...  
JP5989674B2  
JP2016076519A
To provide a material for an organic electroluminescent element having high light-emitting efficiency and an organic electroluminescent element using the same.A compound formed by coupling tertiary amine through orthoterphenyl is contain...  
JP5851929B2  
JP5848698B2  
JP2015532268A
The present invention relates to a method for manufacturing metathesis output including contacting metathesis start material to a metathesis catalyst under metathesis conditions, Ethylene or propylene which used the metathesis catalyst i...  
JP5795619B2  
JP5701832B2  
JP2014510043A5  
JP5623013B2  
JP5554570B2  
JP2014510043A
Crystallinity P2S5・2C5H5A method for changing >C=O machine (I) in a compound into the tautomeric form of >C=S machine (II) or basis (II) in the reaction which brings about a sulfuration reaction product according to the use as a sulphi...  
JP2014055161A
To provide a peptidomimetic compound which inhibits the NS3 protease of the flavivirus of the hepatitis C virus (HCV).The compound is represented by the formula VI.  
JP5436448B2  
JP2014503504A
The present invention relates to the compound which is active inhibitor of complex III of the electron transfer system of a mitochondria, and the medicine constituent which contains the above-mentioned compound in combination with indepe...  
JP5291854B2
The present invention provides a method represented by Scheme 1: wherein X represents I, Br, Cl, alkylsulfonate, or arylsulfonate; Z represents optionally substituted aryl, heteroaryl or alkenyl; catalyst comprises a copper atom or ion, ...  
JP5266499B2
The present invention provides a method represented by Scheme 1: wherein X represents I, Br, Cl, alkylsulfonate, or arylsulfonate; Z represents optionally substituted aryl, heteroaryl or alkenyl; catalyst comprises a copper atom or ion, ...  
JP5248783B2  
JP5230414B2  
JP2013522208A
The present invention is characterized by the solid constituent containing amorphous compound I. The solid distribution thing of the present invention also contains the surface-active agent permitted as the hydrophilic polymer permitted ...  
JP2013087117A
To provide a novel heterocyclic compound and an organic light-emitting element comprising the same.The heterocyclic compound is represented by chemical formula (1). The organic light-emitting element comprises an organic film comprising ...  
JP2013510834A
The present invention relates to the constituent containing the compound of formula (I), and the compound of at least one formula (I) especially a medicine constituent, and medicine. The present invention relates to use of such a compoun...  
JP2013040180A
To provide a wide range of copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds, wherein inexpensive copper is used as a catalyst.For example, this invention relates to reaction methods shown by the following figure an...  
JP5139999B2  
JP2012524121A
The present invention is inhibitor of 11*beta* hydroxy steroid dehydrogenase 1 type enzyme, and non-insulin dependent 2 type diabetes, It is related with this use in the medical treatment of insulin resistance, overweight, a lipid obstac...  
JP2012149204A
To provide a method for producing a cyclic amide compound in high efficiency without generating any harmful by-products, and a method for producing a polyamide by ring-opening polymerization of the cyclic amide compound.The method for pr...  
JP4991527B2  
JP2012113237A
To provide an electrophotographic photoreceptor having excellent wear resistance and electric characteristics and significantly improved scratch resistance in an electrophotographic photoreceptor having a surface layer containing a curab...  
JPWO2010071212A
The object of the present invention does not separate an isocyanate compound and there is in providing the method of closing the end of polymer with a カルボ diimide compound. The present invention is the method of using a compound in...  
JPWO2010071212A1
本発明の目的は、イソシアネート化合物を遊 離させず、カルボジイミド化合物により、ポ リマーの末端を封止する方法を提供すること にある。本発明は、カルボジイミド基を...  
JP2012067103A
To provide a new compound which is useful for treatment of Vancomycin-resistant bacteria infection.Following compounds are illustrated as new peptoid compounds, namely, methyl(2S, 5S, 8R/S)-8-acetamide-2-allyl-9-[6-allyl-9-t-butoxycarbon...  
JP4902361B2  
JP4819223B2  
JP4787021B2  
JP2011190238A
To provide a novel cyclic squaric acid amide derivative or a salt thereof, and a prophylactic and/or therapeutic agent comprising at least one thereof as an active ingredient, which is particularly used for diseases against which a calci...  

Matches 151 - 200 out of 444